Ryvu Therapeutics S.A. (FRA:9Y4)
Germany · Delayed Price · Currency is EUR 5.57
-0.15 (-2.62%)
At close: Nov 21, 2025
Ryvu Therapeutics Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -118.69 | -111.44 | -92.11 | -83.78 | -79.08 | -31.69 | Upgrade |
Depreciation & Amortization | 10.1 | 10.5 | 10.97 | 12.9 | 12.56 | 12.36 | Upgrade |
Loss (Gain) From Sale of Investments | 9.51 | 0.13 | 3.57 | 8.93 | -0.29 | -5.36 | Upgrade |
Other Operating Activities | 7.54 | -8.09 | 7.29 | 17.04 | 22.74 | -0.43 | Upgrade |
Change in Accounts Receivable | 15.03 | -2.94 | -15.91 | -5.56 | -3.79 | 3.74 | Upgrade |
Change in Inventory | 2.08 | 0.91 | -0.36 | 0.2 | -0.28 | -0.09 | Upgrade |
Change in Unearned Revenue | -0.31 | -6.89 | 5.09 | 70.43 | -13.91 | 20.84 | Upgrade |
Change in Other Net Operating Assets | -39.15 | -11.67 | -3.09 | 1.61 | 8.77 | -10.9 | Upgrade |
Operating Cash Flow | -113.94 | -129.48 | -84.55 | 21.32 | -58.89 | -10.64 | Upgrade |
Capital Expenditures | -2.42 | -5.9 | -8.58 | -6.25 | -11.98 | -34.18 | Upgrade |
Investment in Securities | 25.56 | 127.34 | -192.61 | 4.47 | 19.98 | -21.98 | Upgrade |
Other Investing Activities | 4.18 | 15.73 | 5.65 | 2.48 | 0.06 | 0.22 | Upgrade |
Investing Cash Flow | 27.32 | 137.17 | -195.54 | 0.69 | 8.06 | -55.94 | Upgrade |
Long-Term Debt Issued | - | 94.66 | 0.13 | 1.15 | 1.02 | 0.02 | Upgrade |
Total Debt Issued | 0.14 | 94.66 | 0.13 | 1.15 | 1.02 | 0.02 | Upgrade |
Long-Term Debt Repaid | - | -0.44 | -1.79 | -2.51 | -3.21 | -3.95 | Upgrade |
Total Debt Repaid | -2.86 | -0.44 | -1.79 | -2.51 | -3.21 | -3.95 | Upgrade |
Net Debt Issued (Repaid) | -2.72 | 94.22 | -1.66 | -1.37 | -2.19 | -3.93 | Upgrade |
Issuance of Common Stock | - | - | 250.28 | - | 0.24 | 143.05 | Upgrade |
Other Financing Activities | 2.1 | -0.01 | -7.79 | -1.09 | -0.2 | -8.44 | Upgrade |
Financing Cash Flow | -0.62 | 94.21 | 240.83 | -2.46 | -2.15 | 130.69 | Upgrade |
Foreign Exchange Rate Adjustments | -0.1 | 0.24 | -4.72 | -0.87 | - | - | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | 0 | - | Upgrade |
Net Cash Flow | -87.35 | 102.13 | -43.98 | 18.68 | -52.98 | 64.11 | Upgrade |
Free Cash Flow | -116.36 | -135.38 | -93.13 | 15.07 | -70.87 | -44.82 | Upgrade |
Free Cash Flow Margin | -128.71% | -132.78% | -138.39% | 22.01% | -200.12% | -121.28% | Upgrade |
Free Cash Flow Per Share | -5.03 | -5.86 | -4.07 | 0.82 | -3.86 | -2.67 | Upgrade |
Cash Interest Paid | - | 0.01 | 0.1 | 1.09 | 0.2 | 0.21 | Upgrade |
Cash Income Tax Paid | - | - | - | 5.46 | - | - | Upgrade |
Levered Free Cash Flow | 190.06 | 220.52 | 196.8 | -255.29 | -28.13 | -34.27 | Upgrade |
Unlevered Free Cash Flow | 195.29 | 222.9 | 196.86 | -254.61 | -27.85 | -34.03 | Upgrade |
Change in Working Capital | -22.39 | -20.58 | -14.28 | 66.23 | -14.82 | 14.49 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.